Page 1

Global Neurovascular Market: Trends & Opportunities [2013-18]


Executive Summary

The term neurovascular implies the assessment of blood flow and sensation to various parts of the body, including brain, spinal cord and blood vessels. Of the various disorders and conditions associated with the neurovascular system include brain, blood vessel aneurysms, stroke syndrome or vascular malfunction of brain and spinal cord. The global neurovascular industry is characterized by medical innovations and technological advancement, giving shape to a wide range of product offerings while offsetting pricing pressure at the same time. Mergers and acquisitions is a key trend witnessed by the neurovascular industry worldwide in the last few years. The acquisition of prominent players like Ev3 and Micrus has changed the dynamics of the neurovascular space, giving the market a more consolidated form. In addition, various government initiatives to improve healthcare infrastructure have provided the much needed boost to the neurovascular industry. The major companies operating in this market include Stryker, Medtronic, Covidien (Ev3) and Johnson & Johnson (Micrus). The report titled “Global Neurovascular Market: Trends & Opportunities (2013-18)� provides a detailed insight into the neurovascular market. The report analyzes the primary segments of neurovascular disorders and the causes and symptoms associated with the disorder. It also assesses the various treatments available in the market and encompasses its market as well as its segments. The report also incorporates the market share based on various technologies and companies operating in this sphere. The report primarily focuses on the two chief segments of neurovascular disorder: hemorrhagic stroke and ischemic stroke. The report further discusses the various factors driving the neurovascular market in addition to profiling the major companies operating in the market along with their business strategies and expansion plans.


Global Neurovascular Market: An Overview The neurovascular market refers to the treatment pertaining to disorder caused in neurovascular system. The market includes the various surgeries, devices and therapies covered in the treatment of the disorder. The global neurovascular market has witness a significant growth in past few years. The huge patient population with neurological disorder has been the driving factor for this kind of growth .

M

Global Neurovascular Industry Market Size, By Value, 2007-12 (Billion)

2007

2008

2009

2010

2011

2012

Global Neurovascular Industry Market Size, By Value, 2013-18 (Billion)

2013

2014

2015

2016

2017

2018

• The Global Neurovascular industry recorded a CAGR of ………….. during 2007-12. . The industry is forecasted to attain revenue of……. Billion by the end of 2018. 


Global Neurovascular Market: Overview

The Neurovascular market is witnessing mergers and acquisitions enabling the players to make a global presence and expand their product profile. In the present scenario, the vendors are focusing on product innovation and technological advancement to increase their market share in the industry.  . 

Global Neurovascular Industry Market Share, By Technology, 2012

Access Devices

Acute Ischemic stroke devices

Liquid Embolic Systems

Flow Diverters

Remodeling Balloons

ICAD Stents & Balloons

Aneurysm Stents

Embolic Coils

• Embolic Coils is the largest segment of Neurovascular industry with a market share of ………… % in 2012.  •  Flow Diverters had a market share of……….% while remodeling balloons contributed……….%.


Growth Drivers of the Neurovascular Industry Rising number of Diabetic Patients

Increasing case of Hypertension

• …………………………………………………….

• …………………………………………………….

• …………………………………………………….

• …………………………………………………….

• ……………………………………………………

• ……………………………………………………

• …………………………………………………..

• …………………………………………………..

Rising in the Ageing Population • ……………………………………………………. • ……………………………………………………. • …………………………………………………… • …………………………………………………..

Illicit Consumption of NonPrescribed Drugs • ……………………………………………………. • ……………………………………………………. • ……………………………………………………


3.1. Market Sizing and Growth: Actual & Forecast 3.2. Neurovascular Market Share Analysis: By Technology & Major players 3.2.1. Neurovascular Market Share By Technology 3.2.2. Neurovascular Market Share By Major Players 4. Segmentation of Neurovascular Market 4.1. Hemorrhagic Stroke Segment Analysis 4.1.1. Market Sizing and Growth: Actual & Forecast 4.1.2. Market Share Analysis

Table of Contents

4.2. Ischemic Stroke Segment Analysis 4.2.1 Market Sizing and Growth: Actual & Forecast 4.2.2. Market Share Analysis 5. Neurovascular Market: Growth Drivers 5.1. Rising number of Diabetic Patients worldwide 5.2. Increasing Cases of Hypertension 5.3. Rising in the ageing population Worldwide 5.4. Illicit Consumption of Non-prescription Drugs 5.5. Rising Healthcare Expenditure

6. Company Analysis 6.1. Stryker 6.1.1. Business Description 6.1.2. Business Strategies 6.2. Covidien (EV3) 6.2.1. Business Description 6.2.2. Business Strategies


List of Figures and Tables Figure 1: Global Neurovascular Market Size, By Value, 2007-12 (US$ Million) Figure 2: Global Neurovascular Market Size Forecast, By Value, 2013-18 (US$ Million) Figure 3: Global Neurovascular Market Share, By Technology, 2012 (US$ Million) Figure 4: Global Neurovascular Market Share, By Major Players, 2012 Figure 5: Global Hemorrhagic Stroke Market Size, By Value , 2007-12 (US$ Million) Figure 6: Global Hemorrhagic Stroke Market Size Forecast, By Value , 2013-18 (US$ Million) Figure 7: Hemorrhagic Market Share, By Major Players, 2012 (E) Figure 8: Global Ischemic Stroke Market Size, By Value , 2007-12 (US$ Million) Figure 9: Global Ischemic Stroke Market Size Forecast, By Value , 2013-18 (US$ Million) Figure 10: Ischemic Stroke Market Share, By Major Players, 2012 (E) Figure 11: Global Diabetic Population, 2008-12 (Million) Figure 12: Hypertension Population in United States, 2010-15F (Million) Figure 13: Global Ageing Population, 2008-13F (Million) Figure 14: Global Healthcare Spending, 2008-13F (US$ Trillion) Figure 15: Covidien Net Sales, 2007-12 (US$ Bn) Figure 16: Global Sales Overview, By Geography, 2012 Figure 17: Johnson & Johnson Revenue Share, By Business, 2012 Figure 18: Medtronic Sales, By Region, 2012 Table 1: Stryker’s Market Share, 2011

Global Neurovascular Market: Trends & Opportunities (2013-18)  

The report titled “Global Neurovascular Market: Trends & Opportunities (2013-18)” provides a detailed insight into the neurovascular market....

Read more
Read more
Similar to
Popular now
Just for you